On December 28, 2022 BioNTech SE (Nasdaq: BNTX, "BioNTech" or "the Company") reported that CEO and Co-founder Prof. Ugur Sahin, M.D., will present a corporate overview and update at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 9:45 am PST / 12:45 pm ET (Press release, BioNTech, DEC 28, 2022, View Source [SID1234625637]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation will be available via the "Events & Presentations" page in the Investor Relations section on the Company’s website at View Source The replay of the webcast will be archived on the Company’s website for 30 days following the conference.